NCT06487624 2026-04-13An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced TumorsFBD Biologics LimitedPhase 1 Recruiting50 enrolled
NCT02937272 2026-04-03A Study of LY3200882 in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting223 enrolled